“The 40-Gene Expression Profile (40-GEP) Test Identifies Cutaneous Squamous Cell Carcinoma (cSCC) Patients at High Risk of Metastasis Within Lower-Staged Tumors to Better Guide Treatment Decisions”. SKIN The Journal of Cutaneous Medicine, vol. 8, no. 2, Mar. 2024, p. s385, https://doi.org/10.25251/skin.8.supp.385.